Other Species / Isoforms
  K19 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S3-p
_____MTsySYrQss
0 1
K19 (human) _____MTsySYrQss S3-p
K19 (mouse) _____MTsYSYRQTS S3-p
K19 (rat) _____MTSYSYRQsS S3
Y4-p
____MTsySYrQssA
0 1
K19 (human) ____MTsySYrQssA Y4-p
K19 (mouse) ____MTsYSYRQTSA Y4
K19 (rat) ____MTSYSYRQsSA Y4
R7-m1
_MTsySYrQssAtss
0 17
K19 (human) _MTsySYrQssAtss R7-m1
K19 (mouse) _MTsYSYRQTSAMsS R7
K19 (rat) _MTSYSYRQsSAMsS R7
R7-m2
_MTsySYrQssAtss
0 1
K19 (human) _MTsySYrQssAtss R7-m2
K19 (mouse) _MTsYSYRQTSAMsS R7
K19 (rat) _MTSYSYRQsSAMsS R7
S9-p
TsySYrQssAtssFG
Upstream
0 5
Treatment
  • ischemia
K19 (human) TsySYrQssAtssFG S9-p
K19 (mouse) TsYSYRQTSAMsSFG T9
K19 (rat) TSYSYRQsSAMsSYG S9-p
S10-p
sySYrQssAtssFGG
Upstream
1 29
Treatment
  • ischemia
K19 (human) sySYrQssAtssFGG S10-p
K19 (mouse) sYSYRQTSAMsSFGG S10
K19 (rat) SYSYRQsSAMsSYGG S10
T12-p
SYrQssAtssFGGLG
0 11
K19 (human) SYrQssAtssFGGLG T12-p
K19 (mouse) SYRQTSAMsSFGGTG M12
K19 (rat) SYRQsSAMsSYGGMG M12
S13-p
YrQssAtssFGGLGG
0 9
K19 (human) YrQssAtssFGGLGG S13-p
K19 (mouse) YRQTSAMsSFGGTGG S13-p
K19 (rat) YRQsSAMsSYGGMGG S13-p
S14-p
rQssAtssFGGLGGG
0 11
K19 (human) rQssAtssFGGLGGG S14-p
K19 (mouse) RQTSAMsSFGGTGGG S14
K19 (rat) RQsSAMsSYGGMGGG S14
S22-p
FGGLGGGsVrFGPGV
0 13
K19 (human) FGGLGGGsVrFGPGV S22-p
K19 (mouse) FGGTGGGSVrIGsGG S22
K19 (rat) YGGMGGGPVrFGsGG P22
R24-m1
GLGGGsVrFGPGVAF
0 34
K19 (human) GLGGGsVrFGPGVAF R24-m1
K19 (mouse) GTGGGSVrIGsGGVF R24-m1
K19 (rat) GMGGGPVrFGsGGVF R24-m1
R24-m2
GLGGGsVrFGPGVAF
0 7
K19 (human) GLGGGsVrFGPGVAF R24-m2
K19 (mouse) GTGGGSVRIGsGGVF R24
K19 (rat) GMGGGPVRFGsGGVF R24
P27
GGsVrFGPGVAFrAP
0 3
K19 (human) GGsVrFGPGVAFrAP P27
K19 (mouse) GGSVrIGsGGVFrAP S27-p
K19 (rat) GGPVrFGsGGVFrAP S27-p
R32-m1
FGPGVAFrAPsIHGG
0 44
K19 (human) FGPGVAFrAPsIHGG R32-m1
K19 (mouse) IGsGGVFrAPsIHGG R32-m1
K19 (rat) FGsGGVFrAPsIHGG R32-m1
S35-p
GVAFrAPsIHGGsGG
Upstream
Downstream
3 129
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cytoskeletal reorganization
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • Akt_inhibitor_VIII
  • gefitinib
  • hypotonic_buffer
  • LY294002
  • okadaic_acid
  • wortmannin
K19 (human) GVAFrAPsIHGGsGG S35-p
K19 (mouse) GGVFrAPsIHGGSGG S35-p
K19 (rat) GGVFrAPsIHGGsGG S35-p
S40-p
APsIHGGsGGrGVsV
Upstream
0 22
Treatment
  • ischemia
  • MG132_withdrawal
K19 (human) APsIHGGsGGrGVsV S40-p
K19 (mouse) APsIHGGSGGrGVSV S40
K19 (rat) APsIHGGsGGrGVSV S40-p
R43-m1
IHGGsGGrGVsVssA
0 56
K19 (human) IHGGsGGrGVsVssA R43-m1
K19 (mouse) IHGGSGGrGVSVSST R43-m1
K19 (rat) IHGGsGGrGVSVSST R43-m1
R43-m2
IHGGsGGrGVsVssA
0 2
K19 (human) IHGGsGGrGVsVssA R43-m2
K19 (mouse) IHGGSGGRGVSVSST R43
K19 (rat) IHGGsGGRGVSVSST R43
S46-p
GsGGrGVsVssArFV
Upstream
0 6
Treatment
  • ischemia
K19 (human) GsGGrGVsVssArFV S46-p
K19 (mouse) GSGGrGVSVSSTrFV S46
K19 (rat) GsGGrGVSVSSTrIV S46
S48-p
GGrGVsVssArFVSs
0 1
K19 (human) GGrGVsVssArFVSs S48-p
K19 (mouse) GGrGVSVSSTrFVTS S48
K19 (rat) GGrGVSVSSTrIVss S48
S49-p
GrGVsVssArFVSsS
0 1
K19 (human) GrGVsVssArFVSsS S49-p
K19 (mouse) GrGVSVSSTrFVTSS S49
K19 (rat) GrGVSVSSTrIVssS S49
R51-m1
GVsVssArFVSsSSs
0 46
K19 (human) GVsVssArFVSsSSs R51-m1
K19 (mouse) GVSVSSTrFVTSSSG R51-m1
K19 (rat) GVSVSSTrIVssSsG R51-m1
S54
VssArFVSsSSsGAy
0 1
K19 (human) VssArFVSsSSsGAy S54
K19 (mouse) VSSTrFVTSSSGsyG T54
K19 (rat) VSSTrIVssSsGGYV S54-p
S55-p
ssArFVSsSSsGAyG
0 3
K19 (human) ssArFVSsSSsGAyG S55-p
K19 (mouse) SSTrFVTSSSGsyGG S55
K19 (rat) SSTrIVssSsGGYVG S55-p
S57
ArFVSsSSsGAyGGG
0 1
K19 (human) ArFVSsSSsGAyGGG S57
K19 (mouse) TrFVTSSSGsyGGVr S57
K19 (rat) TrIVssSsGGYVGGr S57-p
S58-p
rFVSsSSsGAyGGGy
0 8
K19 (human) rFVSsSSsGAyGGGy S58-p
K19 (mouse) rFVTSSSGsyGGVrG G58
K19 (rat) rIVssSsGGYVGGrG G58
-
gap
0 4
K19 (human) gap -
K19 (mouse) FVTSSSGsyGGVrGG S59-p
K19 (rat) IVssSsGGYVGGrGG G59
-
gap
0 7
K19 (human) gap -
K19 (mouse) VTSSSGsyGGVrGGs Y60-p
K19 (rat) VssSsGGYVGGrGGs Y60
Y61-p
SsSSsGAyGGGyGGV
0 17
K19 (human) SsSSsGAyGGGyGGV Y61-p
K19 (mouse) SGsyGGVRGGsFSGT R64
K19 (rat) sGGYVGGRGGsFSGA R64
Y61
SsSSsGAYGGGyGGV
0 23
K19 (human) SsSSsGAYGGGyGGV Y61
K19 (mouse) SGsyGGVrGGsFSGT R64-m1
K19 (rat) sGGYVGGrGGsFSGA R64-m1
G64
SsGAyGGGyGGVLtA
0 4
K19 (human) SsGAyGGGyGGVLtA G64
K19 (mouse) yGGVrGGsFSGTLAV S67-p
K19 (rat) YVGGrGGsFSGALTV S67-p
Y65-p
sGAyGGGyGGVLtAs
0 4
K19 (human) sGAyGGGyGGVLtAs Y65-p
K19 (mouse) GGVrGGsFSGTLAVs F68
K19 (rat) VGGrGGsFSGALTVT F68
T70-p
GGyGGVLtAsDGLLA
0 2
K19 (human) GGyGGVLtAsDGLLA T70-p
K19 (mouse) GsFSGTLAVsDGLLS A73
K19 (rat) GsFSGALTVTDGLLG T73
S72-p
yGGVLtAsDGLLAGN
0 5
K19 (human) yGGVLtAsDGLLAGN S72-p
K19 (mouse) FSGTLAVsDGLLSGN S75-p
K19 (rat) FSGALTVTDGLLGGN T75
K81-ub
GLLAGNEkLTMQNLN
0 2
K19 (human) GLLAGNEkLTMQNLN K81-ub
K19 (mouse) GLLSGNEKITMQNLN K84
K19 (rat) GLLGGNEKITMQNLN K84
S93-p
NLNDRLAsyLDkVRA
0 12
K19 (human) NLNDRLAsyLDkVRA S93-p
K19 (mouse) NLNDRLAsYLDKVRA S96-p
K19 (rat) NLNDRLAsyLDKVRA S96-p
Y94-p
LNDRLAsyLDkVRAL
0 89
K19 (human) LNDRLAsyLDkVRAL Y94-p
K19 (mouse) LNDRLAsYLDKVRAL Y97
K19 (rat) LNDRLAsyLDKVRAL Y97-p
K97-ub
RLAsyLDkVRALEAA
0 8
K19 (human) RLAsyLDkVRALEAA K97-ub
K19 (mouse) RLAsYLDKVRALEQA K100
K19 (rat) RLAsyLDKVRALEQA K100
K111-ub
ANGELEVkIRDWyQk
0 2
K19 (human) ANGELEVkIRDWyQk K111-ub
K19 (mouse) ANGELEVKIRDWYQK K114
K19 (rat) ANGELEVKIRDWYQK K114
Y116-p
EVkIRDWyQkQGPGP
0 27
K19 (human) EVkIRDWyQkQGPGP Y116-p
K19 (mouse) EVKIRDWYQKQGPGP Y119
K19 (rat) EVKIRDWYQKQGPGP Y119
K118-ub
kIRDWyQkQGPGPSR
0 6
K19 (human) kIRDWyQkQGPGPSR K118-ub
K19 (mouse) KIRDWYQKQGPGPSR K121
K19 (rat) KIRDWYQKQGPGPFR K121
K118-m1
kIRDWyQkQGPGPSR
0 1
K19 (human) kIRDWyQkQGPGPSR K118-m1
K19 (mouse) KIRDWYQKQGPGPSR K121
K19 (rat) KIRDWYQKQGPGPFR K121
Y127-p
GPGPSRDysHyyttI
0 1
K19 (human) GPGPSRDysHyyttI Y127-p
K19 (mouse) GPGPSRDYNHYFKTI Y130
K19 (rat) GPGPFRDYsQYFkTI Y130
S128-p
PGPSRDysHyyttIQ
0 2
K19 (human) PGPSRDysHyyttIQ S128-p
K19 (mouse) PGPSRDYNHYFKTIE N131
K19 (rat) PGPFRDYsQYFkTIE S131-p
Y130-p
PSRDysHyyttIQDL
0 33
K19 (human) PSRDysHyyttIQDL Y130-p
K19 (mouse) PSRDYNHYFKTIEDL Y133
K19 (rat) PFRDYsQYFkTIEDL Y133
Y131-p
SRDysHyyttIQDLR
0 7
K19 (human) SRDysHyyttIQDLR Y131-p
K19 (mouse) SRDYNHYFKTIEDLR F134
K19 (rat) FRDYsQYFkTIEDLR F134
T132-p
RDysHyyttIQDLRD
0 2
K19 (human) RDysHyyttIQDLRD T132-p
K19 (mouse) RDYNHYFKTIEDLRD K135
K19 (rat) RDYsQYFKTIEDLRD K135
T132
RDysHyyTtIQDLRD
0 1
K19 (human) RDysHyyTtIQDLRD T132
K19 (mouse) RDYNHYFKTIEDLRD K135
K19 (rat) RDYsQYFkTIEDLRD K135-ac
T133-p
DysHyyttIQDLRDk
0 2
K19 (human) DysHyyttIQDLRDk T133-p
K19 (mouse) DYNHYFKTIEDLRDK T136
K19 (rat) DYsQYFkTIEDLRDk T136
K140
tIQDLRDKILGAtIE
0 1
K19 (human) tIQDLRDKILGAtIE K140
K19 (mouse) TIEDLRDKILGATID K143
K19 (rat) TIEDLRDkILGATIE K143-ac
K140-ub
tIQDLRDkILGAtIE
0 1
K19 (human) tIQDLRDkILGAtIE K140-ub
K19 (mouse) TIEDLRDKILGATID K143
K19 (rat) TIEDLRDKILGATIE K143
T145-p
RDkILGAtIENSRIV
0 1
K19 (human) RDkILGAtIENSRIV T145-p
K19 (mouse) RDKILGATIDNSKIV T148
K19 (rat) RDkILGATIENSKIV T148
K168-ac
AADDFRTkFETEQAL
0 10
K19 (human) AADDFRTkFETEQAL K168-ac
K19 (mouse) AADDFRTKFETEHAL K171
K19 (rat) AADDFRTkFETEQAL K171-ac
K168-ub
AADDFRTkFETEQAL
0 9
K19 (human) AADDFRTkFETEQAL K168-ub
K19 (mouse) AADDFRTkFETEHAL K171-ub
K19 (rat) AADDFRTKFETEQAL K171
K168-sm
AADDFRTkFETEQAL
0 1
K19 (human) AADDFRTkFETEQAL K168-sm
K19 (mouse) AADDFRTKFETEHAL K171
K19 (rat) AADDFRTKFETEQAL K171
K208
EMQIEGLKEELAyLk
0 1
K19 (human) EMQIEGLKEELAyLk K208
K19 (mouse) EMQIESLKEELAYLK K211
K19 (rat) EMQIENLkEELAYLK K211-ac
K208-ub
EMQIEGLkEELAyLk
0 4
K19 (human) EMQIEGLkEELAyLk K208-ub
K19 (mouse) EMQIESLKEELAYLK K211
K19 (rat) EMQIENLKEELAYLK K211
K208-sm
EMQIEGLkEELAyLk
Downstream
1 0
Effects on Biological Processes:
  • cytoskeletal reorganization
K19 (human) EMQIEGLkEELAyLk K208-sm
K19 (mouse) EMQIESLKEELAYLK K211
K19 (rat) EMQIENLKEELAYLK K211
Y213-p
GLkEELAyLkkNHEE
0 8
K19 (human) GLkEELAyLkkNHEE Y213-p
K19 (mouse) SLKEELAYLKkNHEE Y216
K19 (rat) NLkEELAYLKKNHEE Y216
K215-ub
kEELAyLkkNHEEEI
0 2
K19 (human) kEELAyLkkNHEEEI K215-ub
K19 (mouse) KEELAYLKkNHEEEI K218
K19 (rat) kEELAYLKKNHEEEI K218
K215-sm
kEELAyLkkNHEEEI
0 1
K19 (human) kEELAyLkkNHEEEI K215-sm
K19 (mouse) KEELAYLKkNHEEEI K218
K19 (rat) kEELAYLKKNHEEEI K218
K216-ub
EELAyLkkNHEEEIs
0 5
K19 (human) EELAyLkkNHEEEIs K216-ub
K19 (mouse) EELAYLKkNHEEEIT K219-ub
K19 (rat) EELAYLKKNHEEEIS K219
S223-p
kNHEEEIstLRGQVG
0 1
K19 (human) kNHEEEIstLRGQVG S223-p
K19 (mouse) kNHEEEITALRSQVG T226
K19 (rat) KNHEEEISALRSQVG S226
T224-p
NHEEEIstLRGQVGG
0 1
K19 (human) NHEEEIstLRGQVGG T224-p
K19 (mouse) NHEEEITALRSQVGG A227
K19 (rat) NHEEEISALRSQVGG A227
S234-p
GQVGGQVsVEVDsAP
0 1
K19 (human) GQVGGQVsVEVDsAP S234-p
K19 (mouse) SQVGGQVSVEVDSTP S237
K19 (rat) SQVGGQVSVEVDSTP S237
S239-p
QVsVEVDsAPGTDLA
0 2
K19 (human) QVsVEVDsAPGTDLA S239-p
K19 (mouse) QVSVEVDSTPGVDLA S242
K19 (rat) QVSVEVDSTPGIDLA S242
K247-ub
APGTDLAkILsDMRs
0 1
K19 (human) APGTDLAkILsDMRs K247-ub
K19 (mouse) TPGVDLAKILSEMRS K250
K19 (rat) TPGIDLAKILSEMRS K250
S250-p
TDLAkILsDMRsQyE
0 1
K19 (human) TDLAkILsDMRsQyE S250-p
K19 (mouse) VDLAKILSEMRSQYE S253
K19 (rat) IDLAKILSEMRSQYE S253
S254-p
kILsDMRsQyEVMAE
0 3
K19 (human) kILsDMRsQyEVMAE S254-p
K19 (mouse) KILSEMRSQYEIMAE S257
K19 (rat) KILSEMRSQYEAMAE S257
Y256-p
LsDMRsQyEVMAEQN
0 65
K19 (human) LsDMRsQyEVMAEQN Y256-p
K19 (mouse) LSEMRSQYEIMAEKN Y259
K19 (rat) LSEMRSQYEAMAEKN Y259
K265-ub
VMAEQNRkDAEAWFt
0 1
K19 (human) VMAEQNRkDAEAWFt K265-ub
K19 (mouse) IMAEKNRKDAEATYL K268
K19 (rat) AMAEKNRKDAEAWYL K268
T272-p
kDAEAWFtsrtEELN
0 1
K19 (human) kDAEAWFtsrtEELN T272-p
K19 (mouse) KDAEATYLARIEELN L275
K19 (rat) KDAEAWYLTQIDELN L275
S273-p
DAEAWFtsrtEELNr
0 1
K19 (human) DAEAWFtsrtEELNr S273-p
K19 (mouse) DAEATYLARIEELNT A276
K19 (rat) DAEAWYLTQIDELNT T276
R274-m1
AEAWFtsrtEELNrE
0 1
K19 (human) AEAWFtsrtEELNrE R274-m1
K19 (mouse) AEATYLARIEELNTQ R277
K19 (rat) AEAWYLTQIDELNTQ Q277
T275-p
EAWFtsrtEELNrEV
0 2
K19 (human) EAWFtsrtEELNrEV T275-p
K19 (mouse) EATYLARIEELNTQV I278
K19 (rat) EAWYLTQIDELNTQV I278
R280-m1
srtEELNrEVAGHtE
0 1
K19 (human) srtEELNrEVAGHtE R280-m1
K19 (mouse) ARIEELNTQVAVHSE T283
K19 (rat) TQIDELNTQVAVHTT T283
T286-p
NrEVAGHtEQLQMsr
0 3
K19 (human) NrEVAGHtEQLQMsr T286-p
K19 (mouse) NTQVAVHSEQIQISK S289
K19 (rat) NTQVAVHTTQIQINK T289
S292-p
HtEQLQMsrSEVTDL
0 3
K19 (human) HtEQLQMsrSEVTDL S292-p
K19 (mouse) HSEQIQISKTEVTDL S295
K19 (rat) HTTQIQINKTEVTEL N295
R293-m1
tEQLQMsrSEVTDLR
0 1
K19 (human) tEQLQMsrSEVTDLR R293-m1
K19 (mouse) SEQIQISKTEVTDLR K296
K19 (rat) TTQIQINKTEVTELR K296
S312-p
GLEIELQsQLSMkAA
0 5
K19 (human) GLEIELQsQLSMkAA S312-p
K19 (mouse) GLEIELQsQLSMKAA S315-p
K19 (rat) DLEIELQSQLSMKAA S315
K317-ub
LQsQLSMkAALEDtL
0 2
K19 (human) LQsQLSMkAALEDtL K317-ub
K19 (mouse) LQsQLSMKAALEGTL K320
K19 (rat) LQSQLSMKAALEGTV K320
T323-p
MkAALEDtLAEtEAR
0 6
K19 (human) MkAALEDtLAEtEAR T323-p
K19 (mouse) MKAALEGTLAETEAR T326
K19 (rat) MKAALEGTVAEIEAR T326
T327-p
LEDtLAEtEARFGAQ
0 3
K19 (human) LEDtLAEtEARFGAQ T327-p
K19 (mouse) LEGTLAETEARYGVQ T330
K19 (rat) LEGTVAEIEARYGAQ I330
S343-p
AHIQALIsGIEAQLG
0 1
K19 (human) AHIQALIsGIEAQLG S343-p
K19 (mouse) SQIQSVISGFEAQLS S346
K19 (rat) SHIQGVISSIEVQLS S346
K370
YQRLMDIKsRLEQEI
0 1
K19 (human) YQRLMDIKsRLEQEI K370
K19 (mouse) YKQLMDIKSRLEQEI K373
K19 (rat) YQQLMDIkSrLEQEI K373-ac
K370-ub
YQRLMDIksRLEQEI
0 1
K19 (human) YQRLMDIksRLEQEI K370-ub
K19 (mouse) YKQLMDIKSRLEQEI K373
K19 (rat) YQQLMDIKSrLEQEI K373
S371-p
QRLMDIksRLEQEIA
0 2
K19 (human) QRLMDIksRLEQEIA S371-p
K19 (mouse) KQLMDIKSRLEQEIA S374
K19 (rat) QQLMDIkSrLEQEIA S374
R372
RLMDIksRLEQEIAt
0 4
K19 (human) RLMDIksRLEQEIAt R372
K19 (mouse) QLMDIKSRLEQEIAT R375
K19 (rat) QLMDIkSrLEQEIAT R375-m1
T379-p
RLEQEIAtyRsLLEG
0 1
K19 (human) RLEQEIAtyRsLLEG T379-p
K19 (mouse) RLEQEIATYRSLLEG T382
K19 (rat) rLEQEIATYRSLLEG T382
Y380-p
LEQEIAtyRsLLEGQ
0 11
K19 (human) LEQEIAtyRsLLEGQ Y380-p
K19 (mouse) LEQEIATYRSLLEGQ Y383
K19 (rat) LEQEIATYRSLLEGQ Y383
S382-p
QEIAtyRsLLEGQED
0 2
K19 (human) QEIAtyRsLLEGQED S382-p
K19 (mouse) QEIATYRSLLEGQEA S385
K19 (rat) QEIATYRSLLEGQEA S385
Y391-p
LEGQEDHyNNLsAsk
Upstream
1 259
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Treatment
  • Su11274
  • vanadate
K19 (human) LEGQEDHyNNLsAsk Y391-p
K19 (mouse) LEGQEAHyNNLPtPK Y394-p
K19 (rat) LEGQEAHYNsLSIAK Y394
N393
GQEDHyNNLsAskVL
0 1
K19 (human) GQEDHyNNLsAskVL N393
K19 (mouse) GQEAHyNNLPtPKAI N396
K19 (rat) GQEAHYNsLSIAKAL S396-p
S395-p
EDHyNNLsAskVL__
Upstream
0 18
Regulatory protein:
  • PRP4 (human)
Treatment
  • ischemia
  • lapatinib
  • MG132_withdrawal
K19 (human) EDHyNNLsAskVL__ S395-p
K19 (mouse) EAHyNNLPtPKAI__ P398
K19 (rat) EAHYNsLSIAKAL__ S398
A396
DHyNNLsAskVL___
0 1
K19 (human) DHyNNLsAskVL___ A396
K19 (mouse) AHyNNLPtPKAI___ T399-p
K19 (rat) AHYNsLSIAKAL___ I399
S397-p
HyNNLsAskVL____
0 4
K19 (human) HyNNLsAskVL____ S397-p
K19 (mouse) HyNNLPtPKAI____ P400
K19 (rat) HYNsLSIAKAL____ A400
K398-ub
yNNLsAskVL_____
0 8
K19 (human) yNNLsAskVL_____ K398-ub
K19 (mouse) yNNLPtPKAI_____ K401
K19 (rat) YNsLSIAKAL_____ K401